SCHEMBL2447552

SCHEMBL2447552

CC(C)(C)Nc1nc(Cl)ncc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK17B O94768 1/20 0.43
STK17A Q9UEE5 1/20 0.43
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GLP1R P43220 2/20 0.39
CYP1A2 P05177 1/20 0.37
PDE4A P27815 1/20 0.37
CYP2C19 P33261 1/20 0.37
LATS1 O95835 2/20 0.37
LATS2 Q9NRM7 2/20 0.37
BCL6 P41182 1/20 0.36
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 1/20 0.34
ALDH1A1 P00352 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KMT2A Q03164 2/20 0.33
JAK2 O60674 1/20 0.33
LRRK2 Q5S007 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7177583 0.81 ALDH1A1 (0.50) STK17BSTK17ALMNASMN1; SMN2GLP1R
SCHEMBL2463467 0.81 LMNA (0.39) STK17BSTK17ALMNASMN1; SMN2GLP1R
SCHEMBL12985024 0.81 KMT2A (0.46) STK17BSTK17ALMNASMN1; SMN2GLP1R
SCHEMBL1937585 0.78 STK17B (0.40) STK17BSTK17ABCL6ALDH1A1L3MBTL1
SCHEMBL4535369 0.77 LRRK2 (0.51) STK17BSTK17AALDH1A1L3MBTL1JAK2
SCHEMBL12335037 0.77 FGFR1 (0.42) LATS1LATS2NPC1RAB9ACCNB2
SCHEMBL1938007 0.76 STK17A (0.50) STK17BSTK17ABCL6ALDH1A1L3MBTL1
SCHEMBL16932226 0.74 MAPK8 (0.54) STK17BSTK17AJAK2
SCHEMBL2061903 0.73 STK17A (0.40) STK17BSTK17ALMNAGLP1RLATS1
SCHEMBL14670668 0.72 STK17B (0.39) STK17BSTK17ACYP1A2BCL6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230478-A1 4-Alkyl-substituted diaminopyrimidines Bayer ScienceCrop AG (DE) 2011-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230478-A1 4-Alkyl-substituted diaminopyrimidines DPM1, DPYD, POLR1C STK17B 3187/4885STK17A 2888/4885LMNA 3131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.